High sensitivity C-reactive protein in asthma
- 1 May 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 27 (5), 908-912
- https://doi.org/10.1183/09031936.06.00114405
Abstract
Asthma is characterised by chronic inflammation of the airways, but the relevance of high-sensitivity assays for C-reactive protein (hs-CRP), which are known to be a sensitive marker of low-grade systemic inflammation, has not been fully studied in asthma. The objective was to examine serum hs-CRP levels in patients with asthma and their relationship to clinical characteristics and degree of airway inflammation. Serum hs-CRP levels were cross-sectionally examined in steroid-naive (n = 22) and steroid-inhaling (n = 23) adult patients with asthma and healthy controls (n = 14). All were nonsmokers. Serum hs-CRP levels were significantly increased in steroid-naive patients (mean±sd 1.33±1.48 mg·L−1) compared with controls (0.21±0.30 mg·L−1), but not in patients on inhaled corticosteroid. Among steroid-naive patients, serum hs-CRP levels significantly negatively correlated with indices of pulmonary function (forced expiratory volume in one second/forced vital capacity and forced mid-expiratory flow) and positively with sputum eosinophil count. Among patients on inhaled corticosteroid, hs-CRP levels did not correlate with any indices. In conclusion, an increase in serum C-reactive protein levels measured by high-sensitivity assays may be associated with airflow obstruction and airway inflammation, and may serve as a surrogate marker of airway inflammation in asthma.Keywords
This publication has 17 references indexed in Scilit:
- C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological studyThorax, 2005
- Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based studyThorax, 2004
- Chlamydia pneumoniae Infection and Inflammation in Adults with AsthmaRespiration, 2004
- The association of sensitive systemic inflammation markers with bronchial asthmaAnnals of Allergy, Asthma & Immunology, 2002
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Inflammation in Cardiovascular DiseaseCirculation, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A ProteinAdvances in Immunology, 1983